Media coverage
14
Media coverage
Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Morningstar.com Country/Territory United States Date 4/10/21 URL https://www.morningstar.com/news/business-wire/20211004005316/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021 Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Business Wire Country/Territory United States Date 4/10/21 URL www.businesswire.com/news/home/20211004005316/en Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Yahoo! Finance Country/Territory United States Date 4/10/21 URL https://finance.yahoo.com/news/emd-serono-completes-enrollment-evobrutinib-070000942.html Persons Deirdre Bennett Title EMD Serono : Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet MarketScreener.com Country/Territory United States Date 4/10/21 URL https://www.marketscreener.com/news/latest/EMD-Serono-Completes-Enrollment-of-Evobrutinib-Phase-III-Clinical-Trials-Ahead-of-ECTRIMS-2021--36591261/ Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Maryville Daily Times Country/Territory United States Date 4/10/21 URL https://www.thedailytimes.com/business/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/article_55de1290-5720-5ce5-a787-6768e419765e.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet TD Ameritrade Country/Territory United States Date 4/10/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-277b6960 Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet ADVFN US Country/Territory United States Date 4/10/21 URL https://www.advfn.com/p.php?pid=nmona&article=86199640 Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Elk Valley Times Country/Territory United States Date 4/10/21 URL https://www.elkvalleytimes.com/news/business/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/article_78d1bd37-55b8-5de6-9fc9-236f211e7ebe.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Tullahoma News Country/Territory United States Date 4/10/21 URL https://www.tullahomanews.com/news/business/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/article_b8698e9e-c550-5104-82ec-5a43ce28bf77.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Galveston County Daily News Country/Territory United States Date 4/10/21 URL https://www.galvnews.com/news_ap/business/article_8c879214-7c68-538a-b5b4-8754edd6d206.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Herald Chronicle Country/Territory United States Date 4/10/21 URL https://www.heraldchronicle.com/news/business/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/article_95e9d4f4-0f20-5231-b18a-8b50fbbbf9c1.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Manchester Times Country/Territory United States Date 4/10/21 URL https://www.manchestertimes.com/news/business/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/article_8773651a-170b-528b-9b5b-7698b0fb25b0.html Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Digital Media Net Country/Territory United States Date 4/10/21 URL dmnnewswire.digitalmedianet.com/2021/10/04/emd-serono-completes-enrollment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/ Persons Deirdre Bennett Title EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Acrofan Date 3/10/21 URL https://us.acrofan.com/detail.php?number=540527 Persons Deirdre Bennett